Geistlich Fibro-Gide® vs Connective Tissue Graft for Dental Implant Soft Tissue Enhancement
What You Need to Know Before You Apply
What is the purpose of this trial?
This double blind, randomized, parallel study evaluates the non-inferiority of Geistlich Fibro-Gide® in comparison to connective tissue graft for soft tissue volume augmentation around dental implants
Will I have to stop taking my current medications?
The trial requires that you do not take medications that compromise wound healing, such as chronic steroids, certain blood pressure medications, anti-seizure drugs, or treatments for bone diseases. If you are on these medications, you may need to stop them to participate.
Is the use of Geistlich Fibro-Gide® and Connective Tissue Graft safe for dental implant soft tissue enhancement?
How does the treatment using Geistlich Fibro-Gide® differ from other treatments for dental implant soft tissue enhancement?
What data supports the effectiveness of the treatment Geistlich Fibro-Gide® vs Connective Tissue Graft for Dental Implant Soft Tissue Enhancement?
Research shows that connective tissue grafts are a well-established method for improving gum health and appearance around dental implants, often leading to better outcomes in terms of tissue thickness and esthetics. Additionally, soft tissue augmentation techniques, like those using connective tissue grafts, are known to enhance the appearance and health of the gums around implants, which is crucial for successful dental restorations.810111213
Who Is on the Research Team?
Donald S Clem III, DDS
Principal Investigator
Regenative Solutions
Are You a Good Fit for This Trial?
This trial is for individuals with good oral hygiene needing soft tissue augmentation around dental implants that have been in place for at least 6 months. Participants should not be on medications affecting wound healing, have untreated severe gum disease, uncontrolled diabetes, or a history of frequent nicotine use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Geistlich Fibro-Gide® or Connective Tissue Graft for soft tissue volume augmentation around dental implants
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of gingival soft tissue volume and adverse events
Long-term follow-up
Participants are monitored for long-term safety and effectiveness, including assessments of gingival soft tissue volume and adverse events
What Are the Treatments Tested in This Trial?
Interventions
- Soft tissue flap + Connective Tissue Graft
- Soft tissue flap + Geistlich Fibro-Gide®
Find a Clinic Near You
Who Is Running the Clinical Trial?
Geistlich Pharma AG
Lead Sponsor
Medelis Inc.
Industry Sponsor